Abstract
Background
Liver resection is the standard operative procedure for patients with T2 and T3 gallbladder cancers (GBC). However, the optimal extent of hepatectomy remains unclear.
Methods
We conducted a systematic literature search and meta-analysis to assess the safety and long-term outcomes of wedge resection (WR) vs. segment 4b + 5 resection (SR) in patients with T2 and T3 GBC. We reviewed surgical outcomes (i.e., postoperative complications and bile leak) and oncological outcomes (i.e., liver metastasis, disease-free survival (DFS), and overall survival (OS)).
Results
The initial search yielded 1178 records. Seven studies reported assessments of the above-mentioned outcomes in 1795 patients. WR had significantly fewer postoperative complications than SR, with an odds ratio of 0.40 (95% confidence interval, 0.26 − 0.60; p < 0.001), although there were no significant differences in bile leak between WR and SR. There were no significant differences in oncological outcomes such as liver metastases, 5-year DFS, and OS.
Conclusions
For patients with both T2 and T3 GBC, WR was superior to SR in terms of surgical outcome and comparable to SR in terms of oncological outcomes. WR that achieves margin-negative resection may be a suitable procedure for patients with both T2 and T3 GBC.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are openly available.
References
Hueman MT, Vollmer CM, Jr., Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16(8):2101-15. https://doi.org/10.1245/s10434-009-0538-x.
Rahman R, Simoes EJ, Schmaltz C, Jackson CS, Ibdah JA. Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med. 2017;6(4):874-80. https://doi.org/10.1002/cam4.1044.
Jensen EH, Abraham A, Habermann EB, Al-Refaie WB, Vickers SM, Virnig BA et al. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg. 2009;13(4):722-7. https://doi.org/10.1007/s11605-008-0772-8.
Buettner S, Margonis GA, Kim Y, Gani F, Ethun CG, Poultsides GA et al. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma. Ann Surg Oncol. 2016;23(13):4401-9. https://doi.org/10.1245/s10434-016-5470-2.
Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbecks Arch Surg. 2002;387(5-6):222-8. https://doi.org/10.1007/s00423-002-0318-6.
Nagakawa T, Kayahara M, Ikeda S, Futakawa S, Kakita A, Kawarada H et al. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg. 2002;9(5):569-75. https://doi.org/10.1007/s005340200076.
Kone LB, Bystrom PV, Maker AV. Robotic Surgery for Biliary Tract Cancer. Cancers (Basel). 2022;14(4). https://doi.org/10.3390/cancers14041046.
Aloia TA, Járufe N, Javle M, Maithel SK, Roa JC, Adsay V et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681-90. https://doi.org/10.1111/hpb.12444.
Lee H, Choi DW, Park JY, Youn S, Kwon W, Heo JS et al. Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location. Ann Surg Oncol. 2015;22(8):2779-86. https://doi.org/10.1245/s10434-014-4300-7.
Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009;18(2):307–24, ix. https://doi.org/10.1016/j.soc.2008.12.004.
Foster JM, Hoshi H, Gibbs JF, Iyer R, Javle M, Chu Q et al. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol. 2007;14(2):833-40. https://doi.org/10.1245/s10434-006-9097-6.
Endo I, Shimada H, Fujii Y, Sugita M, Masunari H, Miura Y et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg. 2001;8(6):505-10. https://doi.org/10.1007/s005340100017.
Miyazaki M, Shimizu H, Ohtsuka M, Yoshidome H, Kato A, Yoshitomi H et al. Hepatic S4a + S5 and bile duct resection for gallbladder carcinoma. J Hepatobiliary Pancreat Sci. 2012;19(3):225-9. https://doi.org/10.1007/s00534-011-0500-8.
Patkar S, Patil V, Acharya MR, Kurunkar S, Goel M. Achieving margin negative resection-doing less is justified: oncological outcomes of wedge excision of liver in gallbladder cancer (GBC) surgery. Chin Clin Oncol. 2019;8(4):38. https://doi.org/10.21037/cco.2019.07.07.
Paquet KJ. Appraisal of surgical resection of gallbladder carcinoma with special reference to hepatic resection. J Hepatobiliary Pancreat Surg. 1998;5(2):200-6. https://doi.org/10.1007/s005340050034.
Yoshikawa T, Araida T, Azuma T, Takasaki K. Bisubsegmental liver resection for gallbladder cancer. Hepatogastroenterology. 1998;45(19):14-9.
Suzuki M, Yamamoto K, Unno M, Katayose Y, Endo K, Oikawa M et al. Detection of perfusion areas of the gallbladder vein on computed tomography during arterial portography (CTAP)--the background for dual S4a.S5 hepatic subsegmentectomy in advanced gallbladder carcinoma. Hepatogastroenterology. 2000;47(33):631–5.
Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T et al. Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study. J Hepatobiliary Pancreat Surg. 2009;16(2):204-15. https://doi.org/10.1007/s00534-009-0044-3.
Nag HH, Nekarakanti PK, Sachan A, Nabi P, Tyagi S. Bi-segmentectomy versus wedge hepatic resection in extended cholecystectomy for T2 and T3 gallbladder cancer: A matched case-control study. Ann Hepatobiliary Pancreat Surg. 2021;25(4):485-91. https://doi.org/10.14701/ahbps.2021.25.4.485.
Chen M, Cao J, Xiang Y, Ma X, Bai Y, Lai Q et al. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. Surgery. 2021;169(6):1304-11. https://doi.org/10.1016/j.surg.2020.12.039.
Kwon W, Kim H, Han Y, Hwang YJ, Kim SG, Kwon HJ et al. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. Br J Surg. 2020;107(10):1334-43. https://doi.org/10.1002/bjs.11618.
Yu LH, Yuan B, Fu XH, Yu WL, Liu J, Zhang YJ. Does Anatomic Resection Get More Benefits than Wedge Hepatectomy on the Prognosis for pT3 Unsuspected Gallbladder Cancer? J Laparoendosc Adv Surg Tech A. 2019;29(11):1414-8. https://doi.org/10.1089/lap.2018.0690.
Lee SE, Kim SW, Han HS, Lee WJ, Yoon DS, Cho BH et al. Surgical Strategy for T2 Gallbladder Cancer: Nationwide Multicenter Survey in Korea. J Korean Med Sci. 2018;33(28):e186. https://doi.org/10.3346/jkms.2018.33.e186.
Horiguchi A, Miyakawa S, Ishihara S, Miyazaki M, Ohtsuka M, Shimizu H et al. Gallbladder bed resection or hepatectomy of segments 4a and 5 for pT2 gallbladder carcinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2013;20(5):518-24. https://doi.org/10.1007/s00534-012-0584-9.
Glenn F, Hays DM. The scope of radical surgery in the treatment of malignant tumors of the extrahepatic biliary tract. Surg Gynecol Obstet. 1954;99(5):529-41.
Sasaki R, Takeda Y, Hoshikawa K, Takahashi M, Funato O, Nitta H et al. Long-term results of central inferior (S4a+S5) hepatic subsegmentectomy and pancreatoduodenectomy combined with extended lymphadenectomy for gallbladder carcinoma with subserous or mild liver invasion (pT2-3) and nodal involvement: a preliminary report. Hepatogastroenterology. 2004;51(55):215-8.
Taura K. Letter to the editor regarding "Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study". Surgery. 2021;170(3):987-8. https://doi.org/10.1016/j.surg.2021.03.009.
Marubashi S, Gotoh K, Akita H, Takahashi H, Ito Y, Yano M et al. Anatomical versus non-anatomical resection for hepatocellular carcinoma. Br J Surg. 2015;102(7):776-84. https://doi.org/10.1002/bjs.9815.
Brown KM, Albania MF, Samra JS, Kelly PJ, Hugh TJ. Propensity score analysis of non-anatomical versus anatomical resection of colorectal liver metastases. BJS Open. 2019;3(4):521-31. https://doi.org/10.1002/bjs5.50154.
Chen G, Wang J, Chen K, Kang M, Zhang H, Jin X et al. Relationship Between Postoperative Complications and the Prognosis of Gastric Carcinoma Patients Who Underwent Surgical Resection: A Systematic Review and Meta-Analysis. Cancer Control. 2021;28:10732748211011955. https://doi.org/10.1177/10732748211011955.
Ueda K, Murakami J, Tanaka T, Nakamura T, Yoshimine S, Hamano K. Postoperative Complications and Cancer Recurrence: Impact on Poor Prognosis of Lower Lobe Cancer. Ann Thorac Surg. 2020;109(6):1750-6. https://doi.org/10.1016/j.athoracsur.2019.12.061.
Pucher PH, Aggarwal R, Qurashi M, Darzi A. Meta-analysis of the effect of postoperative in-hospital morbidity on long-term patient survival. Br J Surg. 2014;101(12):1499-508. https://doi.org/10.1002/bjs.9615.
Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford). 2016;18(11):872-8. https://doi.org/10.1016/j.hpb.2016.05.016.
Chiba N, Shimazu M, Ochiai S, Yokozuka K, Gunji T, Okihara M et al. Resection of Hepatic Lesions Perfused by the Cholecystic Vein Using Indocyanine Green Navigation in Patients with cT2 Gallbladder Cancer. World J Surg. 2019;43(2):608-14. https://doi.org/10.1007/s00268-018-4810-8.
Kai K, Satoh S, Watanabe T, Endo Y. Evaluation of cholecystic venous flow using indocyanine green fluorescence angiography. J Hepatobiliary Pancreat Sci. 2010;17(2):147-51. https://doi.org/10.1007/s00534-009-0111-9.
Liu F, Wu ZR, Hu HJ, Jin YW, Ma WJ, Wang JK et al. Current status and future perspectives of minimally invasive surgery in gallbladder carcinoma. ANZ J Surg. 2021;91(3):264-8. https://doi.org/10.1111/ans.16125.
Agarwal AK, Javed A, Kalayarasan R, Sakhuja P. Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study. HPB (Oxford). 2015;17(6):536-41. https://doi.org/10.1111/hpb.12406.
Palanisamy S, Patel N, Sabnis S, Palanisamy N, Vijay A, Palanivelu P et al. Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention. Surg Endosc. 2016;30(6):2442-8. https://doi.org/10.1007/s00464-015-4495-0.
Machado MA, Makdissi FF, Surjan RC. Totally Laparoscopic Hepatic Bisegmentectomy (s4b+s5) and Hilar Lymphadenectomy for Incidental Gallbladder Cancer. Ann Surg Oncol. 2015;22 Suppl 3:S336-9. https://doi.org/10.1245/s10434-015-4650-9.
Dou C, Zhang C, Zhang C, Liu J. Propensity Score Analysis of Outcomes Following Laparoscopic or Open Radical Resection for Gallbladder Cancer in T2 and T3 Stages. J Gastrointest Surg. 2022;26(7):1416-24. https://doi.org/10.1007/s11605-022-05288-y.
Han HS, Yoon YS, Agarwal AK, Belli G, Itano O, Gumbs AA et al. Laparoscopic Surgery for Gallbladder Cancer: An Expert Consensus Statement. Dig Surg. 2019;36(1):1-6. https://doi.org/10.1159/000486207.
Ohtani T, Shirai Y, Tsukada K, Muto T, Hatakeyama K. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging. 1996;21(3):195-201. https://doi.org/10.1007/s002619900045.
Jung SE, Lee JM, Lee K, Rha SE, Choi BG, Kim EK et al. Gallbladder wall thickening: MR imaging and pathologic correlation with emphasis on layered pattern. Eur Radiol. 2005;15(4):694-701. https://doi.org/10.1007/s00330-004-2539-2.
Fujita N, Noda Y, Kobayashi G, Kimura K, Yago A. Diagnosis of the depth of invasion of gallbladder carcinoma by EUS. Gastrointest Endosc. 1999;50(5):659-63. https://doi.org/10.1016/s0016-5107(99)80015-7.
Maithel SK. Optimal surgical management of T2 gallbladder cancer-wedge resection. Surgery. 2021;169(6):1312-3. https://doi.org/10.1016/j.surg.2021.01.017.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
An ethics statement is not applicable because this study is based exclusively on published literature.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Synopsis for Table of Contents
We conducted a systematic literature search and meta-analysis to assess the safety and long-term outcomes of wedge resection (WR) vs. segment 4b + 5 resection (SR) in patients with T2 and T3 GBC. In this meta-analysis, WR was superior to SR in terms of surgical outcome and comparable to SR in terms of oncological outcomes.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Matsui, S., Tanioka, T., Nakajima, K. et al. Surgical and Oncological Outcomes of Wedge Resection Versus Segment 4b + 5 Resection for T2 and T3 Gallbladder Cancer: a Meta-Analysis. J Gastrointest Surg 27, 1954–1962 (2023). https://doi.org/10.1007/s11605-023-05698-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-023-05698-6